REVOLADE 25 mg cp pellic

REVOLADE 25 mg cp pellic revolade Revolade 50mg Tablet contains the active constituent eltrombopag It is used to treat low platelet counts caused by immune primary thrombocytopenia or revolade Revolade for the treatment of adult chronic immune thrombocytopenic purpura Revolade is an orphan medicinal product indicated for

revolade Initial dose regimen: Adults: Revolade should be initiated at a dose of 25 mg once daily For chronic HCV patients of East-Southeast-Asian ancestry, Revolade

revolade On this page about Revolade you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated